Patents by Inventor Sheela Waugh

Sheela Waugh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9365855
    Abstract: The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to 4-1BB; pharmaceutical compositions comprising such 4-1BB aptamers; and methods of making and using the same.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: June 14, 2016
    Assignee: SOMALOGIC, INC.
    Inventors: Jonathan Vaught, Daniel I. Resnicow, Sheela Waugh, Sheri K. Wilcox, Daniel J. Schneider
  • Patent number: 9206429
    Abstract: Aptamers that bind IL-6 are provided. Pharmaceutical compositions comprising IL-6 aptamers are provided, as well as methods of treating conditions using the aptamers are also provided.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: December 8, 2015
    Assignees: SomaLogic, Inc., Otsuka Pharmaceutical Co., Ltd
    Inventors: Shashi Gupta, Masao Hirota, Daniel J. Schneider, Tomoki Suzuki, Thale C. Jarvis, Yuichi Ishikawa, Ikuo Murakami, Amy Gelinas, Sheela Waugh, Nebojsa Janjic
  • Publication number: 20140315986
    Abstract: Aptamers that bind IL-6 are provided. Pharmaceutical compositions comprising IL-6 aptamers are provided, as well as methods of treating conditions using the aptamers are also provided.
    Type: Application
    Filed: March 12, 2014
    Publication date: October 23, 2014
    Applicants: Otsuka Pharmaceutical Co., Ltd., SomaLogic, Inc.
    Inventors: Shashi Gupta, Masao Hirota, Daniel J. Schneider, Tomoki Suzuki, Thale C. Jarvis, Yuichi Ishikawa, Ikuo Murakami, Amy Gelinas, Sheela Waugh, Nebojsa Janjic
  • Publication number: 20140081011
    Abstract: The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to 4-1BB; pharmaceutical compositions comprising such 4-1BB aptamers; and methods of making and using the same.
    Type: Application
    Filed: November 19, 2013
    Publication date: March 20, 2014
    Applicant: SOMALOGIC, INC.
    Inventors: Jonathan Vaught, Daniel I. Resnicow, Sheela Waugh, Sheri K. Wilcox, Daniel J. Schneider
  • Patent number: 8598140
    Abstract: The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to ?-NGF; pharmaceutical compositions comprising such ?-NGF aptamers; and methods of making and using the same.
    Type: Grant
    Filed: April 12, 2011
    Date of Patent: December 3, 2013
    Assignees: SomaLogic, Inc., OTSUKA Pharmaceutical Co., Ltd.
    Inventors: Daniel J. Schneider, Akihiko Hisaminato, Sheela Waugh, Daniel Resnicow, Akira Nagabukuro, Toshihide Ono
  • Publication number: 20130012693
    Abstract: The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to ?-NGF; pharmaceutical compositions comprising such ?-NGF aptamers; and methods of making and using the same.
    Type: Application
    Filed: April 12, 2011
    Publication date: January 10, 2013
    Applicants: OTSUKA PHARMACEUTICAL CO., LTD., SOMALOGIC, INC.
    Inventors: Daniel J. Schneider, Akihiko Hisaminato, Sheela Waugh, Daniel Resnicow, Akira Nagabukuro, Toshihide Ono
  • Publication number: 20120322862
    Abstract: The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to 4-1BB; pharmaceutical compositions comprising such 4-1BB aptamers; and methods of making and using the same.
    Type: Application
    Filed: March 3, 2011
    Publication date: December 20, 2012
    Applicant: SOMALOGIC, INC.
    Inventors: Jonathan Vaught, Daniel I. Resnicow, Sheela Waugh, Sheri K. Wilcox, Daniel J. Schneider